NFE2L2 and systemic lupus erythematosus: On the other hand, mycophenolate mofetile is increasingly used in SLE and preserves the Nrf2 system in the liver as well as in the kidney, which might contribute to the broad therapeutic tolerability of the drug (73, 74).